US87918A1051
US87918A1051
Teladoc Health, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 50/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±65.5% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.1x as much as the broader market.
Beta (Market Relation)
2.14x
Above averageVolatility (5Y p.a.)
65.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-97.1%
5-Year HorizonSharpe Ratio
-0.75
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -39.1% |
| 3 Years | 59.4% | -79.8% | -0.6 | -33.3% |
| 5 Years | 65.5% | -97.1% | -0.75 | -46.9% |
| 10 Years | 60.8% | -98.5% | -0.22 | -10.7% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 2.14 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (65.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -98.5% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
2 ISS Score: 2 / 10
Audit Risk
2 ISS Score: 2 / 10
Board Risk
1 ISS Score: 1 / 10
Short Ratio
8.12